Cancer susceptibility has been attributed to at least one heterozygous genetic alteration in a tumor suppressor gene (TSG). It has been hypothesized that subtle variations in TSG expression can promote cancer development. However, this hypothesis has not yet been definitively supported in vivo. Pten is a TSG frequently lost in human cancer and mutated in inherited cancer-predisposition syndromes. Here we analyze Pten hypermorphic mice (Pten hy/+), expressing 80% normal levels of Pten. Pten hy/+ mice develop a spectrum of tumors, with breast tumors occurring at the highest penetrance. All breast tumors analyzed here retained two intact copies of Pten and maintained Pten levels above heterozygosity. Notably, subtle downregulation of Pten altered the steady-state biology of the mammary tissues and the expression profiles of genes involved in cancer cell proliferation. We present an alterative working model for cancer development in which subtle reductions in the dose of TSGs predispose to tumorigenesis in a tissue-specific manner. © 2010 Nature America, Inc. All rights reserved.

Subtle variations in Pten dose determine cancer susceptibility / Alimonti, A.; Carracedo, A.; Clohessy, J. G.; Trotman, L. C.; Nardella, C.; Egia, A.; Salmena, L.; Sampieri, K.; Haveman, W. J.; Brogi, E.; Richardson, A. L.; Zhang, J.; Pandolfi, P. P.. - In: NATURE GENETICS. - ISSN 1061-4036. - 42:5(2010), pp. 454-458. [10.1038/ng.556]

Subtle variations in Pten dose determine cancer susceptibility

Nardella C.;
2010

Abstract

Cancer susceptibility has been attributed to at least one heterozygous genetic alteration in a tumor suppressor gene (TSG). It has been hypothesized that subtle variations in TSG expression can promote cancer development. However, this hypothesis has not yet been definitively supported in vivo. Pten is a TSG frequently lost in human cancer and mutated in inherited cancer-predisposition syndromes. Here we analyze Pten hypermorphic mice (Pten hy/+), expressing 80% normal levels of Pten. Pten hy/+ mice develop a spectrum of tumors, with breast tumors occurring at the highest penetrance. All breast tumors analyzed here retained two intact copies of Pten and maintained Pten levels above heterozygosity. Notably, subtle downregulation of Pten altered the steady-state biology of the mammary tissues and the expression profiles of genes involved in cancer cell proliferation. We present an alterative working model for cancer development in which subtle reductions in the dose of TSGs predispose to tumorigenesis in a tissue-specific manner. © 2010 Nature America, Inc. All rights reserved.
5
Alimonti, A.; Carracedo, A.; Clohessy, J. G.; Trotman, L. C.; Nardella, C.; Egia, A.; Salmena, L.; Sampieri, K.; Haveman, W. J.; Brogi, E.; Richardson, A. L.; Zhang, J.; Pandolfi, P. P.
Subtle variations in Pten dose determine cancer susceptibility / Alimonti, A.; Carracedo, A.; Clohessy, J. G.; Trotman, L. C.; Nardella, C.; Egia, A.; Salmena, L.; Sampieri, K.; Haveman, W. J.; Brogi, E.; Richardson, A. L.; Zhang, J.; Pandolfi, P. P.. - In: NATURE GENETICS. - ISSN 1061-4036. - 42:5(2010), pp. 454-458. [10.1038/ng.556]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11572/251823
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 245
  • Scopus 431
  • ???jsp.display-item.citation.isi??? ND
social impact